To cite this paper use one of the standards below:
The immunomodulatory and antitumoral activities of tarin, a four peptide-subunit lectin purified to homogeneity from taro (Colocasia esculenta), were demonstrated both in vitro and in a murine model. Tarin in its nano-encapsulated form has been reported as controlling cell proliferation against human glioblastoma (U-87-MG) and mammary adenocarcinoma (MDA-MB-231) culture lines, displaying similar effectiveness to cisplatin and temozolomide. The mechanisms involved in tarin anticancer activity were triggered in an MDA-MB-231 cell lineage, while antimetastatic effects were investigated using a homogeneous tarin preparation in increasing 1, 2 or 4-fold concentrations compared to the IC50 of 71.38 µg/mL loaded in 144 nm nano-liposomes. The antimetastatic effects of the nano-encapsulated tarin were evaluated by the scratch assay followed by photo-microscopy documentation. Nano-encapsulated tarin inhibited mammary adenocarcinoma cell migration after 24 h and 48 h even at the minimal concentration, higher than the conventional chemotherapeutic cyclophosphamide. When compared to free tarin, cytotoxic effects seem to be delayed from 24 h to 48 h exposure in inhibiting MDA-MB-231 cell migration, while antimetastatic effects did not respond to increased nano-encapsulated tarin concentrations, compatible to the sustained and controlled release of tarin from nanoliposomes, which may lower the effective dose associated to a longer and sustained effect on tumorigenic cells. Ultrastructural MDA-MB-231 alterations after treatment with the nano-liposomal preparation were observed by transmission electron microscopy, characterized by the presence of autophagosomes, indicating mammary adenocarcinoma cell death. On the other hand, cells treated with free tarin exhibited intracellular content leakage and endoplasmic reticulum proliferation, indicating late stage cell death. The investigation of cell death by flow cytometry employing Annexin V FITC and PI as markers indicated increased apoptotic cells after 24 h of treatment. Further investigations are in progress to reveal the activated molecular signalling pathway following treatment with the nano-liposomal preparation, as well as its cytotoxicity against healthy human HFF-1 fibroblasts.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper